Lipopolysaccharide-induced tau phosphorylation and kinase activity - modulation, but not mediation, by corticotropin-releasing factor receptors

European Journal of Neuroscience

Volumn 34, Issue 3, 2011, Pages 448-456

  Roe, Allyson D ^a   Staup, Michael A ^a   Serrats, Jordi ^b   Sawchenko, Paul E ^b   Rissman, Robert A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Alzheimer's disease; Hippocampus; Immunohistochemistry; Mouse; Stress; Western blot

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE; TAU KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; IMMUNE RESPONSE; MALE; MODULATION; MOUSE; NONHUMAN; PARALLEL DESIGN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STRESS;

ANIMALS; BODY TEMPERATURE; ENZYME ACTIVATION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TAU PROTEINS;

EID: 79960953205     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07764.x     Document Type: Article

References (68)

1. Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. & Hyman, B.T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 42, 631-639.
2. Bale, T.L. & Vale, W.W. (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol., 44, 525-557.
3. Bale, T.L., Contarino, A., Smith, G.W., Chan, R., Gold, L.H., Sawchenko, P.E., Koob, G.F., Vale, W.W. & Lee, K.F. (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet., 24, 410-414.
4. Bale, T.L., Picetti, R., Contarino, A., Koob, G.F., Vale, W.W. & Lee, K.F. (2002) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci., 22, 193-199.
5. Bennecib, M., Gong, C.X., Grundke-Iqbal, I. & Iqbal, K. (2000) Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett., 485, 87-93.
6. Bhaskar, K., Konerth, M., Kokiko-Cochran, O.N., Cardona, A., Ransohoff, R.M. & Lamb, B.T. (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron, 68, 19-31.
7. Braak, H. & Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82, 239-259.
8. Chevalier-Larsen, E. & Holzbaur, E.L. (2006) Axonal transport and neurodegenerative disease. Biochim. Biophys. Acta, 1762, 1094-1108.
9. Cohen, P. & Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol., 2, 769-776.
10. Dayas, C.V., Buller, K.M., Crane, J.W., Xu, Y. & Day, T.A. (2001) Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur. J. Neurosci., 14, 1143-1152.
11. Dixit, R., Ross, J.L., Goldman, Y.E. & Holzbaur, E.L. (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science, 319, 1086-1089.
12. Dong, H., Goico, B., Martin, M., Csernansky, C.A., Bertchume, A. & Csernansky, J.G. (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience, 127, 601-609.
13. Elmquist, J.K., Scammell, T.E., Jacobson, C.D. & Saper, C.B. (1996) Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J. Comp. Neurol., 371, 85-103.
14. Elmquist, J.K., Scammell, T.E. & Saper, C.B. (1997) Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci., 20, 565-570.
15. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. & Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron, 3, 519-526.
16. Goedert, M., Spillantini, M.G., Cairns, N.J. & Crowther, R.A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron, 8, 159-168.
17. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E. & Hyman, B.T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol., 41, 17-24.
18. Gong, C.X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I. & Iqbal, K. (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem., 275, 5535-5544.
19. Greenberg, S.G. & Davies, P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl Acad. Sci. USA, 87, 5827-5831.
20. Greenberg, S.G., Davies, P., Schein, J.D. & Binder, L.I. (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem., 267, 564-569.
21. Herman, J.P. & Cullinan, W.E. (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci., 20, 78-84.
22. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R.C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J.M., Nowotny, P., Che, L.K., Norton, J., Morris, J.C., Reed, L.A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, F., Tannenberg, T., Dodd, P.R., Hayward, N., Kwok, J.B., Schofield, P.R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B.A., Hardy, J., Goate, A., van Swieten, J., Mann, D., Lynch, T. & Heutink, P. (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702-705.
23. Imai, Y. & Kohsaka, S. (2002) Intracellular signaling in M0CSF-induced microglia activation: role of Iba1. Glia, 40, 164-174.
24. Kang, J.E., Cirrito, J.R., Dong, H., Csernansky, J.G. & Holtzman, D.M. (2007) Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc. Natl Acad. Sci. USA, 104, 10673-10678.
25. Kiank, C., Tache, Y. & Larauche, M. (2003) Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav. Immun., 24, 41-48.
26. Kitazawa, M., Oddo, S., Yamasaki, T.R., Green, K.N. & LaFerla, F.M. (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci., 25, 8843-8853.
27. Kitazawa, M., Trinh, D.N. & LaFerla, F.M. (2008) Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Ann. Neurol., 64, 15-24.
28. Lee, D.C., Rizer, J., Selenica, M.L., Reid, P., Kraft, C., Johnson, A., Blair, L., Gordon, M.N., Dickey, C.A. & Morgan, D. (2010) LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J. Neuroinflammation, 7, 56.
29. Li, Y., Liu, L., Barger, S.W. & Griffin, W.S. (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci., 23, 1605-1611.
30. Liu, S.J., Zhang, A.H., Li, H.L., Wang, Q., Deng, H.M., Netzer, W.J., Xu, H. & Wang, J.Z. (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J. Neurochem., 87, 1333-1344.
31. Mercken, M., Vandermeeren, M., Lübke, U., Six, J., Boons, J., Van de Voorde, A., Martin, J.J. & Gheuens, J. (1992) Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol., 84, 265-272.
32. Miyaji, M., Kortum, R.L., Surana, R., Li, W., Woolard, K.D., Simpson, R.M., Samelson, L.E. & Sommers, C.L. (2009) Genetic evidence for the role of ERK activation in a lymphoproliferative disease of mice. Proc. Natl Acad. Sci. USA, 106, 14502-14507.
33. Patrick, G.N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P. & Tsai, L.H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature, 402, 615-622.
34. Phiel, C.J., Wilson, C.A., Lee, V.M. & Klein, P.S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature, 423, 435-439.
35. Piedrahita, D., Hernandez, I., Lopez-Tobon, A., Fedorov, D., Obara, B., Manjunath, B.S., Boudreau, R.L., Davidson, B., Laferla, F., Gallego-Gomez, J.C., Kosik, K.S. & Cardona-Gomez, G.P. (2010) Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. J. Neurosci., 30, 13966-13976.
36. Planel, E., Yasutake, K., Fujita, S.C. & Ishiguro, K. (2001) Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem., 276, 34298-34306.
37. Planel, E., Miyasaka, T., Launey, T., Chui, D.H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y. & Takashima, A. (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J. Neurosci., 24, 2401-2411.
38. Planel, E., Richter, K.E., Nolan, C.E., Finley, J.E., Liu, L., Wen, Y., Krishnamurthy, P., Herman, M., Wang, L., Schachter, J.B., Nelson, R.B., Lau, L.F. & Duff, K.E. (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J. Neurosci., 27, 3090-3097.
39. Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M. & Schellenberg, G.D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol., 43, 815-825.
40. Quan, N., Stern, E.L., Whiteside, M.B. & Herkenham, M. (1999) Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol., 93, 72-80.
41. Radley, J.J., Gosselink, K.L. & Sawchenko, P.E. (2009) A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J. Neurosci., 29, 7330-7340.
42. Rissman, R.A. (2009) Stress-induced tau phosphorylation: functional neuroplasticity or neuronal vulnerability? J. Alzheimers Dis., 18, 453-457.
43. Rissman, R.A., Lee, K.F., Vale, W. & Sawchenko, P.E. (2007) Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J. Neurosci., 27, 6552-6562.
44. Romanovsky, A.A., Simons, C.T. & Kulchitsky, V.A. (1998) "Biphasic" fevers often consist of more than two phases. Am. J. Physiol., 275, R323-R331.
45. Roy, S., Zhang, B., Lee, V.M. & Trojanowski, J.Q. (2005) Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol., 109, 5-13.
46. Rudaya, A.Y., Steiner, A.A., Robbins, J.R., Dragic, A.S. & Romanovsky, A.A. (2005) Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am. J. Physiol. Regul. Integr. Comp. Physiol., 289, R1244-R1252.
47. Sagar, S.M., Price, K.J., Kasting, N.W. & Sharp, F.R. (1995) Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res. Bull., 36, 381-392.
48. Savage, M.J., Lin, Y.G., Ciallella, J.R., Flood, D.G. & Scott, R.W. (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci., 22, 3376-3385.
49. Sawchenko, P.E., Brown, E.R., Chan, R.K., Ericsson, A., Li, H.Y., Roland, B.L. & Kovacs, K.J. (1996) The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog. Brain Res., 107, 201-222.
50. Sawchenko, P.E., Li, H.Y. & Ericsson, A. (2000) Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog. Brain Res., 122, 61-78.
51. Schiltz, J.C. & Sawchenko, P.E. (2002) Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci., 22, 5606-5618.
52. Serrats, J., Schiltz, J.C., Garcia-Bueno, B., van Rooijen, N., Reyes, T.M. & Sawchenko, P.E. (2010) Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron, 65, 94-106.
53. Shu, S., Ju, G. & Fan, L. (1988) The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett., 85, 169-171.
54. Smith, G.W., Aubry, J.M., Dellu, F., Contarino, A., Bilezikjian, L.M., Gold, L.H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C.A., Sawchenko, P.E., Koob, G.F., Vale, W. & Lee, K.F. (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron, 20, 1093-1102.
55. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. & Ghetti, B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA, 95, 7737-7741.
56. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. & Mandelkow, E.M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol., 156, 1051-1063.
57. Stevens, S.L., Shaw, T.E., Dykhuizen, E., Lessov, N.S., Hill, J.K., Wurst, W. & Stenzel-Poore, M.P. (2003) Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J. Cereb. Blood Flow Metab., 23, 1151-1159.
58. Tanaka, T., Zhong, J., Iqbal, K., Trenkner, E. & Grundke-Iqbal, I. (1998) The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Lett., 426, 248-254.
59. Tsatsanis, C., Androulidaki, A., Dermitzaki, E., Gravanis, A. & Margioris, A.N. (2007) Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J. Cell. Physiol., 210, 774-783.
60. Wang, J.Z., Grundke-Iqbal, I. & Iqbal, K. (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res. Mol. Brain Res., 38, 200-208.
61. Wang, M.J., Lin, S.Z., Kuo, J.S., Huang, H.Y., Tzeng, S.F., Liao, C.H., Chen, D.C. & Chen, W.F. (2007) Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J. Immunol., 179, 6204-6214.
62. Wilson, R.S., Evans, D.A., Bienias, J.L., Mendes de Leon, C.F., Schneider, J.A. & Bennett, D.A. (2003) Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology, 61, 1479-1485.
63. Wilson, R.S., Bennett, D.A., Mendes de Leon, C.F., Bienias, J.L., Morris, M.C. & Evans, D.A. (2005) Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology, 30, 11-17.
64. Wilson, R.S., Arnold, S.E., Schneider, J.A., Kelly, J.F., Tang, Y. & Bennett, D.A. (2006) Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology, 27, 143-153.
65. Wilson, R.S., Schneider, J.A., Boyle, P.A., Arnold, S.E., Tang, Y. & Bennett, D.A. (2007) Chronic distress and incidence of mild cognitive impairment. Neurology, 68, 2085-2092.
66. Zhang, R. & Li, S. (2009) COX-2 as a novel target of CRF family peptides' participating in inflammation. Biochem. Biophys. Res. Commun., 382, 483-485.
67. Zhang, Y.H., Lu, J., Elmquist, J.K. & Saper, C.B. (2003) Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain. J. Comp. Neurol., 463, 3-12.
68. Zimmermann, S. & Moelling, K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science, 286, 1741-1744.